The Supreme Cannabis Company (TSXV:FIRE) smashed its previous records with the release of its financial and operating results for Q1 2019 on Wednesday (November 14), which saw a revenue spike of 229 percent from Q1 2018 to C$5.14 million.

Alongside the year-on-year growth was a 45 percent increase from the previous quarter, which came in at C$3.55 million. While the company’s losses were also up, hitting C$5.39 million versus Q1 2018’s C$2.18 million, Supreme attributed some of the positive results to its flagship cannabis brand, 7ACRES.

“Q1 2019 results are continued validation for the successful execution of our strategy for our 7ACRES business to establish a competitive advantage in quality driven regulated cultivation at scale,” Navdeep Dhaliwal, CEO of Supreme, said in the press release.

“We’ve established valuable intellectual property and laid a strong foundation for 2019 by amassing coast-to-coast distribution for what we believe is the only premium High-End Cannabis™ grown at scale in the country. Moving forward, our branding and distribution for 7ACRES will accelerate, as we’re confident that consumers will further fuel our growth as they recognize the standard 7ACRES has set in the market for premium dried flower.”

The company saw a busy quarter through expansion plans and supply agreements; in early September, Supreme was approved for additional production capacity at its 7ACRES facility.

Health Canada greenlit the company’s plans to add 20,000 square feet of flowering rooms, bringing total capacity to 90,000 square feet and boosting annual production potential from 10,000 kilograms (kg) to 13,330 kg. The company expects the flowering rooms to be completed in December 2018.

Later that month, Supreme signed a 12-month guaranteed supply agreement for 7ACRES dried cannabis with Tilray (NASDAQ:TLRY). The deal, which has an estimated value of C$12 million, began as of October 1 to support medical cannabis patients in Canada.

Supreme also signed agreements with six Canadian provinces during this quarter to help supply the legal adult-use market following legalization.

Supreme shares were down 5.75 percent on the TSX Venture Exchange as of 12:15 p.m. EST on November 14, hitting C$1.64 a stock. On TradingView, shares of the company are currently ranked as a “Sell,” with 15 against, 9 “Neutral” and two as a “Buy.”

Don’t forget to follow us @INN_Resource for real-time updates!

Securities Disclosure: I, Olivia Da Silva, hold no direct investment interest in any company mentioned in this article.

Editorial Disclosure: The Supreme Cannabis Company is a client of the Investing News Network. This article is not paid-for content.

Ensuring estoraTMpatients have seamless access to their high-quality medical cannabis products

World-Class Extractions Inc. (CSE:PUMP)(FRA:WCF)(OTCQB:WCEXF) (the “Company” or “World-Class”) is pleased to announce that its subsidiary Pineapple Express Delivery Inc. (“Pineapple Express Delivery” or “PED”), a leading logistics technology company offering compliant and secure delivery of controlled substances and regulated products, has partnered with CannTrust Inc. to bring same-day and next-day delivery to estoraTM medical cannabis patients in Ontario

Keep reading... Show less

American cannabis sales hit US$17.5 billion in 2020, a research group’s new study shows.

Meanwhile, a Canadian cannabis producer began offering CBD beverages in the US, another move that shows how interested Canadians are in the overall US cannabis market at the moment.

Keep reading... Show less

An Emerging Markets Sponsored Commentary

Some pretty important news out of health and wellness; beverage and natural products company BevCanna Enterprises Inc. (CSE:BEV, Q:BVNNF, FSE:7BC) this week. For those of you following the Company with us, stay tuned.

Keep reading... Show less

As investors continue to prioritize cannabis opportunities in the US, market watchers expect mergers and acquisitions (M&A) to play a role in the future for Canadian companies.

A consolidation trend has been expected in the Canadian cannabis space for some time now based on the size of the market compared to the number of operations in the country.

Keep reading... Show less

The product will include polyphenols known to have significant health benefits.

BioHarvest Sciences Inc. (CSE: BHSC) (“BioHarvest” or the “Company”) has reached an important milestone in its development program of additional Nutraceuticals. The olive-based Nutraceutical product scheduled for market availability in the second half of 2022 will contain the following unique matrix of polyphenols: hydroxytyrosol, trosol, and verbascoside. These compounds are the major polyphenols in naturally grown olives and are responsible for the high antioxidant activity of olives and olive oil. Importantly, the BioHarvest olive-based Nutraceutical product will provide all the benefits of olives and olive oil with a low calorie count per serving.

Keep reading... Show less